Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	First Hawaiian announces up to $75M stock repurchase program » 08:06 02/08/21 02/08 08:06 02/08/21 08:06 FHB First Hawaiian $24.63 / +0.07 (+0.29%) First Hawaiian announced… First Hawaiian announced that the Company's Board of Directors has adopted a stock repurchase program for up to $75M of its outstanding common stock during 2021. ShowHide Related Items >><< Street Research Earnings Events FHB First Hawaiian $24.63 / +0.07 (+0.29%) 11/19/20 JPMorgan First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo FHB First Hawaiian $24.63 / +0.07 (+0.29%) 01/22/21 First Hawaiian reports Q4 core EPS 50c, consensus 44c 10/23/20 First Hawaiian reports Q3 EPS 50c, consensus 28c 02/10/21 Winter Financial Services Virtual Symposium

Over a month ago
Earnings	First Hawaiian reports Q4 core EPS 50c, consensus 44c » 07:05 01/22/21 01/22 07:05 01/22/21 07:05 FHB First Hawaiian $25.46 / -0.48 (-1.85%) Total stockholders'… Total stockholders' equity was $2.7B at both December 31, 2020 and September 30, 2020. The tier 1 leverage, common equity tier 1 and total capital ratios were 8.00%, 12.47% and 13.72%, respectively, at December 31, 2020, compared with 7.91%, 12.22% and 13.47%, respectively, at September 30, 2020. "We finished 2020 with a strong quarter and continued to support our customers and meet their evolving needs by leveraging technology, digital channels and our deep relationships," said Bob Harrison, Chairman, President and CEO. "In these uncertain times, our ability to remain agile and innovative positions us well to continue supporting our customers and the community." ShowHide Related Items >><< Company News Street Research Earnings Events FHB First Hawaiian $25.46 / -0.48 (-1.85%) 07/24/20 First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24 FHB First Hawaiian $25.46 / -0.48 (-1.85%) 11/19/20 JPMorgan First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo FHB First Hawaiian $25.46 / -0.48 (-1.85%) 10/23/20 First Hawaiian reports Q3 EPS 50c, consensus 28c 07/24/20 First Hawaiian reports Q2 EPS 15c, consensus 22c 01/22/21 First Hawaiian - FHB

Over a quarter ago
Recommendations	First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan » 08:17 11/19/20 11/19 08:17 11/19/20 08:17 FHB First Hawaiian $22.03 / -0.48 (-2.13%) JPMorgan analyst Steven… JPMorgan analyst Steven Alexopoulos raised the firm's price target on First Hawaiian to $18.50 from $15.50 and keeps an Underweight rating on the shares after hosting meetings with management. ShowHide Related Items >><< Company News Street Research Earnings On The Fly FHB First Hawaiian $22.03 / -0.48 (-2.13%) 07/24/20 First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24 07/20/20 S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices FHB First Hawaiian $22.03 / -0.48 (-2.13%) 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 06/29/20 UBS First Hawaiian downgraded to Sell from Neutral at UBS FHB First Hawaiian $22.03 / -0.48 (-2.13%) 10/23/20 First Hawaiian reports Q3 EPS 50c, consensus 28c 07/24/20 First Hawaiian reports Q2 EPS 15c, consensus 22c FHB First Hawaiian $22.03 / -0.48 (-2.13%) 07/20/20 Fly Intel: After-Hours Movers
Earnings	First Hawaiian reports Q3 EPS 50c, consensus 28c » 08:08 10/23/20 10/23 08:08 10/23/20 08:08 FHB First Hawaiian $16.78 / +0.64 (+3.97%) The tier 1 leverage,… The tier 1 leverage, common equity tier 1 and total capital ratios were 7.91%, 12.22% and 13.47%, respectively, at September 30, 2020, compared with 7.75%, 11.86% and 13.11%, respectively, at June 30, 2020. "In spite of the current economic environment, we reported solid financial results for the third quarter," said Bob Harrison, Chairman, President and CEO. "These are still challenging times, but the re-opening of the local economy, and more recently, the pre-testing program for trans-Pacific travel, are important steps toward the state's economic recovery." ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FHB First Hawaiian $16.78 / +0.64 (+3.97%) 07/24/20 First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24 07/20/20 S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices 04/24/20 First Hawaiian suspends stock repurchase program FHB First Hawaiian $16.78 / +0.64 (+3.97%) 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 06/29/20 UBS First Hawaiian downgraded to Sell from Neutral at UBS FHB First Hawaiian $16.78 / +0.64 (+3.97%) 07/24/20 First Hawaiian reports Q2 EPS 15c, consensus 22c 04/24/20 First Hawaiian reports Q1 EPS 30c, consensus 38c FHB First Hawaiian $16.78 / +0.64 (+3.97%) 07/20/20 Fly Intel: After-Hours Movers 10/23/20 First Hawaiian - FHB
Earnings	First Hawaiian reports Q2 EPS 15c, consensus 22c » 08:01 07/24/20 07/24 08:01 07/24/20 08:01 FHB First Hawaiian $18.61 / +0.64 (+3.56%) The tier 1 leverage,… The tier 1 leverage, common equity tier 1 and total capital ratios were 7.75%, 11.86% and 13.11%, respectively, at June 30, 2020, compared with 8.63%, 11.65% and 12.90%, respectively, at March 31, 2020. "I am very proud of our teams' extraordinary efforts to manage through the pandemic's disruption with agility and resilience while ensuring the health and safety of their co-workers, customers and community," said Bob Harrison, Chairman, President and CEO. "During this difficult time for our local economy, we focused our efforts on creating stability by offering relief assistance to customers and support to the community. Our teams leveraged technology investments to develop an online application portal that enabled us to secure over $940 million in PPP loans for 6,000 small business customers. We also successfully launched the Aloha for Hawaii Fund, which supported the restaurant industry, and donated $1 million to non-profits for COVID-19 relief. Another $1 million was donated to the Stronger Together Fund to support the 2020 public high school graduates as they transition to the next phase of their lives." ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FHB First Hawaiian $18.61 / +0.64 (+3.56%) 07/24/20 First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24 07/20/20 S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices 04/24/20 First Hawaiian suspends stock repurchase program FHB First Hawaiian $18.61 / +0.64 (+3.56%) 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 06/29/20 UBS First Hawaiian downgraded to Sell from Neutral at UBS FHB First Hawaiian $18.61 / +0.64 (+3.56%) 04/24/20 First Hawaiian reports Q1 EPS 30c, consensus 38c 01/28/20 First Hawaiian reports Q4 adj. EPS 54c, consensus 51c FHB First Hawaiian $18.61 / +0.64 (+3.56%) 07/20/20 Fly Intel: After-Hours Movers 07/24/20 First Hawaiian - FHB

Hot Stocks	First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24 04:55 07/24/20 07/24 04:55 07/24/20 04:55 FHB First Hawaiian $18.61 / +0.64 (+3.56%) , EBS Emergent BioSolutions $89.01 / -4.99 (-5.31%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FHB EBS FHB First Hawaiian $18.61 / +0.64 (+3.56%) 07/20/20 S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices 07/20/20 First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24 04/24/20 First Hawaiian suspends stock repurchase program EBS Emergent BioSolutions $89.01 / -4.99 (-5.31%) 07/24/20 Emergent BioSolutions to replace Caesars in S&P 400 at open on 7/24 07/21/20 Emergent BioSolutions falls -9.6% 07/21/20 Emergent BioSolutions falls -8.7% 07/21/20 Emergent BioSolutions falls -8.4% FHB EBS FHB First Hawaiian $18.61 / +0.64 (+3.56%) 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 06/29/20 UBS First Hawaiian downgraded to Sell from Neutral at UBS EBS Emergent BioSolutions $89.01 / -4.99 (-5.31%) 07/17/20 Cantor Fitzgerald Emergent BioSolutions price target raised to $110 from $85 at Cantor Fitzgerald 07/02/20 Wells Fargo Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo 06/26/20 Raymond James Vaxart already had vaccine deals with Emergent, Kindred, notes Raymond James 06/08/20 Guggenheim Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim FHB EBS FHB First Hawaiian $18.61 / +0.64 (+3.56%) 04/24/20 First Hawaiian reports Q1 EPS 30c, consensus 38c 01/28/20 First Hawaiian reports Q4 adj. EPS 54c, consensus 51c EBS Emergent BioSolutions $89.01 / -4.99 (-5.31%) 04/30/20 Emergent BioSolutions reports Q1 EPS (1c), consensus 1c 02/20/20 Emergent BioSolutions sees FY20 revenue $1.175B-$1.275B, consensus $1.23B 02/20/20 Emergent BioSolutions sees Q1 revenue $190M-$215M, consensus $262.06M 02/20/20 Emergent BioSolutions reports Q4 EPS $1.57, consensus $1.73 FHB EBS FHB First Hawaiian $18.61 / +0.64 (+3.56%) 07/20/20 Fly Intel: After-Hours Movers EBS Emergent BioSolutions $89.01 / -4.99 (-5.31%) 06/08/20 Fly Intel: Wall Street's top stories for Monday 06/08/20 Fly Intel: Wall Street's top stories at midday 04/27/20 Fly Insider: Accelerate Diagnostics, Abbott among week's notable insider trades 04/23/20 Fly Intel: After-Hours Movers 07/24/20 First Hawaiian - FHB 07/30/20 Emergent BioSolutions - EBS
On The Fly	Fly Intel: After-Hours Movers » 18:49 07/20/20 07/20 18:49 07/20/20 18:49 TBK Triumph Bancorp $23.31 / -0.75 (-3.12%) , IBM IBM $126.42 / +1.275 (+1.02%) , CDNS Cadence Design $103.85 / +3.62 (+3.61%) , FBK FB Financial $22.75 / -0.83 (-3.52%) , NBEV NewAge $1.75 / +0.075 (+4.49%) , HIBB Hibbett Sports $22.53 / -0.745 (-3.20%) , PBIB Ticker changed to LMST $0.00 / + (+0.00%) , XENE Xenon Pharmaceuticals $12.80 / +0.61 (+5.00%) , FHB First Hawaiian $15.57 / -0.295 (-1.86%) , HSTO Histogen $3.11 / -0.02 (-0.64%) , CCK Crown Holdings $69.63 / +1.375 (+2.01%) , ACAD Acadia $55.47 / +0.535 (+0.97%) , PIRS Pieris Pharmaceuticals $3.27 / +0.01 (+0.31%) , CTSO CytoSorbents $11.51 / +0.19 (+1.68%) , KNSA Kiniksa $23.92 / +0.61 (+2.62%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XENE TBK PIRS NBEV KNSA IBM HSTO HIBB FHB FBK CTSO CDNS CCK ACAD XENE Xenon Pharmaceuticals $12.80 / +0.61 (+5.00%) 03/31/20 Xenon Pharmaceuticals expects cash to fund operations into 2022 03/31/20 Xenon Pharmaceuticals says no change to previous guidance on FX301 03/31/20 Xenon Pharmaceuticals says no change to previous guidance on NBI-921352 03/31/20 Xenon Pharmaceuticals expects results from Phase 2 study of XEN007 in 2020 TBK Triumph Bancorp $23.31 / -0.75 (-3.12%) 07/08/20 Triumph subsidiary acquires assets of Transport Financial Solutions 03/26/20 Triumph Bancorp nominates Debra Bradford, Laura Easly to board of directors PIRS Pieris Pharmaceuticals $3.27 / +0.01 (+0.31%) 07/20/20 Pieris phase 1 studies of PRS-343 placed on partial clinical hold by FDA 03/23/20 Pieris Pharmaceuticals provides update on Servier collaboration 01/27/20 Pieris Pharmaceuticals drops 10% after ASKA opts not to exercise PRS-080 option NBEV NewAge $1.75 / +0.075 (+4.49%) 07/20/20 New Age Beverages jumps 114% after pact to create '$500M enterprise' 07/20/20 New Age to combine with ARIIX, additional E-commerce/direct selling firms 03/27/20 New Age Beverages tweets new Nestea drinks now available at some Costco stores 03/26/20 New Age Beverages announces expansion, donations of immune-system products KNSA Kiniksa $23.92 / +0.61 (+2.62%) 07/16/20 Kiniksa receives Orphan Drug designation for rilonacept for pericarditis 06/29/20 Kiniksa says Phase 3 trial of rilonacept meets efficacy endpoints 06/17/20 Kiniksa announces publication of clinical outcomes with mavrilimumab in COVID-19 06/16/20 Consonance Capital Management reports 11% passive stake in Kiniksa IBM IBM $126.42 / +1.275 (+1.02%) 07/20/20 IBM says dealing with a weaker dollar 07/20/20 IBM says still not providing guidance for 2020 07/20/20 IBM 'not immune' to macroeconomic environment 07/20/20 IBM says has renewed focus to 'do more' in terms of CSR HSTO Histogen $3.11 / -0.02 (-0.64%) 07/20/20 Histogen announces common stock purchase agreement with Lincoln Park Capital 07/14/20 Histogen completes patient enrollment for HST 001 Phase 1b/2a trial 06/03/20 Histogen says enrollment underway in Phase 1b/2a trial of HST 001 06/01/20 Histogen doses first patient in Phase 1b/2a trial of HST 001 HIBB Hibbett Sports $22.53 / -0.745 (-3.20%) 07/20/20 Hibbett Sports jumps 30% after forecasting Q2 total SSS up in excess of 70% y/y 07/20/20 Hibbett Sports not providing FY21 outlook at this time 07/20/20 Hibbett Sports: Sales results 'exceptional' at this point in the quarter 07/20/20 Hibbett Sports sees 1H total SSS up approximately 20% y/y FHB First Hawaiian $15.57 / -0.295 (-1.86%) 07/20/20 S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices 07/20/20 First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24 04/24/20 First Hawaiian suspends stock repurchase program FBK FB Financial $22.75 / -0.83 (-3.52%) 04/24/20 First Financial names James Gordon as CFO, succeeding J. Bruce Hildebrand 01/21/20 Fly Intel: After Hours Movers 01/21/20 FB Financial announces merger with Franklin Financial Network CTSO CytoSorbents $11.51 / +0.19 (+1.68%) 06/24/20 CytoSorbents launches CytoSorb in nine Latin American countries 06/09/20 CytoSorbents awarded $2.9M contract by U.S. Defense Health Agency 05/12/20 CytoSorbents: CytoSorb is E.U. approved to remove rivaroxaban 05/05/20 CytoSorbents expects Q2 products sales to exceed Q1 CDNS Cadence Design $103.85 / +3.62 (+3.61%) 06/15/20 Cadence teams with TSMC, Microsoft to reduce chip design signoff schedules 02/13/20 Cadence Design acquires Integrand Software, terms not disclosed 02/12/20 Fly Intel: After Hours Movers 01/23/20 TowerJazz, Cadence Design, Kyiv Polytechnic opening new analog design lab CCK Crown Holdings $69.63 / +1.375 (+2.01%) 07/20/20 Crown Holdings falls 7% to $64.61 after Q2 results, Q3, FY20 guidance 07/20/20 Crown Holdings to add additional production lines to certain plants in 2021 07/20/20 Crown Holdings CEO says Q2 performance 'solid' 05/15/20 Einhorn's Greenlight adds Altria, exits GM, DXC in Q1 ACAD Acadia $55.47 / +0.535 (+0.97%) 07/20/20 Acadia Phase 3 CLARITY study misses primary endpoint 07/20/20 Acadia says FDA accepts sNDA filing for nuplazid 07/20/20 Acadia: Phase 3 CLARITY study did not achieve statistical significance 06/15/20 Acadia submits Nuplazid sNDA to FDA TBK IBM CDNS FBK NBEV HIBB PBIB XENE FHB HSTO CCK ACAD PIRS CTSO KNSA TBK Triumph Bancorp $23.31 / -0.75 (-3.12%) 07/10/20 Fly Intel: Top five analyst upgrades 07/10/20 DA Davidson Triumph Bancorp upgraded to Buy from Neutral at DA Davidson 07/10/20 DA Davidson Triumph Bancorp upgraded to Buy from Neutral at DA Davidson 06/02/20 Wells Fargo Triumph Bancorp downgraded to Underweight at Wells Fargo on valuation IBM IBM $126.42 / +1.275 (+1.02%) 07/08/20 Stifel IBM consensus for second half, 2021 appears 'reasonable,' says Stifel 06/09/20 DA Davidson DA Davidson says Cloudera sale 'increasingly likely,' IBM seen as possible buyer 04/21/20 Morgan Stanley Krishna years away from returning IBM to sustainable growth, says Morgan Stanley 04/21/20 Wedbush IBM price target lowered to $140 from $155 at Wedbush CDNS Cadence Design $103.85 / +3.62 (+3.61%) 07/16/20 DA Davidson Cadence Design price target raised to $115 from $90 at DA Davidson 07/14/20 Wells Fargo Cadence Design price target raised to $110 from $100 at Wells Fargo 06/15/20 RBC Capital Cadence Design price target raised to $101 from $85 at RBC Capital 05/28/20 Wells Fargo Cadence Design price target raised to $100 from $87 at Wells Fargo FBK FB Financial $22.75 / -0.83 (-3.52%) 01/02/20 Truist SunTrust raises price targets on select regional banks on improved margins 12/09/19 Sandler O'Neill FB Financial downgraded to Hold from Buy at Sandler O'Neill 10/23/19 Raymond James FB Financial downgraded to Market Perform on valuation at Raymond James 10/23/19 Raymond James FB Financial downgraded to Market Perform from Outperform at Raymond James NBEV NewAge $1.75 / +0.075 (+4.49%) 04/14/20 Alliance Global Partners New Age Beverages at Alliance Global Partners 03/11/20 Compass Point New Age Beverages price target lowered to $4 from $9 at Compass Point 07/22/19 Northland Northland downgrades New Age Beverages on 'more realistic' estimates 07/22/19 Northland New Age Beverages downgraded to Market Perform from Outperform at Northland HIBB Hibbett Sports $22.53 / -0.745 (-3.20%) 07/10/20 Susquehanna Hibbett Sports price target raised to $30 from $25 at Susquehanna 07/10/20 Susquehanna Foot Locker upgraded to Positive from Neutral at Susquehanna 07/02/20 Fly Intel: Top five analyst upgrades 07/02/20 BofA BofA double upgrades Hibbett Sports on COVID market share gains PBIB Ticker changed to LMST $0.00 / + (+0.00%) XENE Xenon Pharmaceuticals $12.80 / +0.61 (+5.00%) 07/20/20 Needham Xenon Pharmaceuticals initiated with a Buy at Needham 06/01/20 Fly Intel: Top five analyst initiations 05/31/20 Jefferies Xenon Pharmaceuticals assumed with a Buy at Jefferies 03/25/20 Fly Intel: Top five analyst initiations FHB First Hawaiian $15.57 / -0.295 (-1.86%) 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 06/29/20 UBS First Hawaiian downgraded to Sell from Neutral at UBS HSTO Histogen $3.11 / -0.02 (-0.64%) CCK Crown Holdings $69.63 / +1.375 (+2.01%) 07/15/20 Jefferies Canpack's new Scranton plant 'modest negative' for Ball, Crown, says Jefferies 07/15/20 Citi Can-Pack entry to U.S. would be negative for Ball, Crown, says Citi 07/13/20 Jefferies Ball Corp. assumed with a Hold at Jefferies 07/13/20 Jefferies Crown Holdings assumed with a Buy at Jefferies ACAD Acadia $55.47 / +0.535 (+0.97%) 07/16/20 JPMorgan JPMorgan boosts Acadia target to $66, likes setup into depression data 07/13/20 Oppenheimer Relmada Therapeutics initiated with an Outperform at Oppenheimer 07/09/20 RBC Capital Acadia price target raised to $61 from $58 at RBC Capital 07/07/20 Fly Intel: Top five analyst upgrades PIRS Pieris Pharmaceuticals $3.27 / +0.01 (+0.31%) 03/13/20 Baird Baird upgrades Pieris Pharmaceuticals as pipeline updates expected 03/13/20 Baird Pieris Pharmaceuticals upgraded to Outperform from Neutral at Baird 03/12/20 H.C. Wainwright Increased visibility in 2020 expected for Pieris, says H.C. Wainwright 01/27/20 H.C. Wainwright Pieris Pharmaceuticals price target raised to $9 from $7 at H.C. Wainwright CTSO CytoSorbents $11.51 / +0.19 (+1.68%) 06/02/20 B. Riley Securities CytoSorbents gaining relevance as COVID-19 treatment, says B. Riley FBR 05/14/20 B. Riley Securities CytoSorbents label expansion could significantly expand use, says B. Riley FBR 05/06/20 B. Riley Securities B. Riley boosts CytoSorbents target, says Portola deal highlights value 03/25/20 Dawson James CytoSorbents being used for COVID-19 in Italy, China, says Dawson James KNSA Kiniksa $23.92 / +0.61 (+2.62%) 07/17/20 JPMorgan Kiniksa risk/reward attractive into Phase 2 data, says JPMorgan 06/29/20 Goldman Sachs Kiniksa price target raised to $33 from $29 at Goldman Sachs 06/29/20 Wedbush Kiniksa price target raised to $38 from $30 at Wedbush 04/01/20 Fly Intel: Top five analyst initiations XENE TBK PIRS NBEV KNSA IBM HIBB FHB FBK CTSO CDNS CCK ACAD XENE Xenon Pharmaceuticals $12.80 / +0.61 (+5.00%) 05/21/20 Xenon Pharmaceuticals reports Q1 EPS (22c), consensus (32c) TBK Triumph Bancorp $23.31 / -0.75 (-3.12%) 07/20/20 Triumph Bancorp reports Q2 EPS 25c, consensus 7c 04/20/20 Triumph Bancorp reports Q1 EPS (18c), consensus 28c 01/21/20 Triumph Bancorp reports Q4 EPS 66c, consensus 61c PIRS Pieris Pharmaceuticals $3.27 / +0.01 (+0.31%) 05/11/20 Pieris Pharmaceuticals reports Q1 EPS (7c), consensus (17c) NBEV NewAge $1.75 / +0.075 (+4.49%) 04/14/20 New Age Beverages sees Q1 revenue $62M-$64M, consensus $56.62M 03/16/20 New Age Beverages reports Q4 EPS (83c) with charge, consensus (8c) KNSA Kiniksa $23.92 / +0.61 (+2.62%) 04/28/20 Kiniksa expects cash reserves to fund operating plan into 2H21 04/28/20 Kiniksa reports Q4 EPS (48c), consensus (63c) 02/26/20 Kiniksa reports Q4 EPS (58c), consensus (62c) IBM IBM $126.42 / +1.275 (+1.02%) 07/20/20 IBM says 'prudent' management enabled it to expand gross profit margin 07/20/20 IBM reports Q2 cloud & cognitive revenue $5.7B, up 3% 07/20/20 IBM reports Q2 adjusted EPS $2.18, consensus $2.07 07/20/20 Notable companies reporting after market close HIBB Hibbett Sports $22.53 / -0.745 (-3.20%) 05/26/20 Hibbett Sports reports Q1 adjusted EPS 31c, consensus 65c 03/20/20 Hibbett Sports says not providing FY21 guidance due to COVID-19 impact 03/20/20 Hibbett Sports reports Q4 adjusted EPS 51c, consensus 62c FHB First Hawaiian $15.57 / -0.295 (-1.86%) 04/24/20 First Hawaiian reports Q1 EPS 30c, consensus 38c 01/28/20 First Hawaiian reports Q4 adj. EPS 54c, consensus 51c FBK FB Financial $22.75 / -0.83 (-3.52%) 07/20/20 FB Financial reports Q2 adjusted EPS 74c, consensus 48c 04/27/20 FB Financial reports Q1 EPS 2c, may not compare to consensus 55c 01/21/20 FB Financial reports Q4 adjusted EPS 70c, consensus 66c CTSO CytoSorbents $11.51 / +0.19 (+1.68%) 07/20/20 CytoSorbents sees Q2 revenue approximately $9.8M, consensus $9.25M 05/05/20 CytoSorbents reports Q1 EPS (10c), consensus (13c) 03/05/20 CytoSorbents reports FY19 EPS (60c), consensus (64c) 03/05/20 CytoSorbents reports Q4 revenue $7.4M, consensus $6.8M CDNS Cadence Design $103.85 / +3.62 (+3.61%) 07/20/20 Cadence Design sees FY20 adjusted EPS $2.50-$2.56, consensus $2.46 07/20/20 Cadence Design sees Q3 adjusted EPS 59c-61c, consensus 63c 07/20/20 Cadence Design reports Q2 adjusted EPS 66c, consensus 52c CCK Crown Holdings $69.63 / +1.375 (+2.01%) 07/20/20 Crown Holdings sees FY20 adjusted EPS $5.10-$5.25, consensus $5.00 07/20/20 Crown Holdings sees Q3 adjusted EPS $1.50-$1.60, consensus $1.53 07/20/20 Crown Holdings reports Q2 adjusted EPS $1.33, consensus $1.30 04/20/20 Crown Holdings withdraws 2020 guidance ACAD Acadia $55.47 / +0.535 (+0.97%) 05/07/20 Acadia cuts FY20 NUPLAZID sales view to $420M-$450M 05/07/20 Acadia Pharmaceuticals reports Q1 EPS (57c), consensus (48c) 02/26/20 Acadia reports Q4 EPS (34c), consensus (36c) 22 Jul 22 Jul 14 May 22 Jan 18 Sep NBEV IBM HIBB CTSO CCK NBEV NewAge $1.75 / +0.075 (+4.49%) 02/13/20 Zoetic raises capital to accelerate U.S. plans, Proactive says IBM IBM $126.42 / +1.275 (+1.02%) 06/12/20 Microsoft won't sell facial recognition technology to police, WaPo reports 06/09/20 IBM exits facial recognition business amid criticism of technology, CNBC says 05/22/20 IBM announces first workforce reduction under new CEO, WSJ says 05/21/20 IBM slashing jobs in far-reaching headcount reduction, Bloomberg says HIBB Hibbett Sports $22.53 / -0.745 (-3.20%) 03/11/20 Modell's files for Chapter 11 bankruptcy, Reuters reports CTSO CytoSorbents $11.51 / +0.19 (+1.68%) 06/19/20 BARDA halts funding for treatments for severe forms of COVID-19, NYT reports CCK Crown Holdings $69.63 / +1.375 (+2.01%) 07/15/20 Giorgi Global to invest $366M in new PA aluminum can plant, WFMZ says NBEV KNSA IBM HIBB CTSO CCK ACAD NBEV NewAge $1.75 / +0.075 (+4.49%) 03/16/20 Fly Intel: Pre-market Movers KNSA Kiniksa $23.92 / +0.61 (+2.62%) 06/29/20 Fly Intel: Wall Street's top stories for Monday 06/29/20 Fly Intel: Wall Street's top stories at midday 05/13/20 Fly Intel: After-Hours Movers 03/31/20 Fly Intel: Wall Street's top stories for Tuesday IBM IBM $126.42 / +1.275 (+1.02%) 07/20/20 Fly Intel: What to watch in IBM's earnings report 06/24/20 Fly Intel: Wall Street's top stories at midday 06/13/20 Week in review: How Trump's policies moved stocks 06/12/20 Fly Intel: Wall Street's top stories for Friday HIBB Hibbett Sports $22.53 / -0.745 (-3.20%) 07/02/20 Livongo Health downgrade, Avis upgrade among today's top calls on Wall Street 05/26/20 Fly Intel: Pre-market Movers 03/20/20 Fly Intel: Pre-market Movers CTSO CytoSorbents $11.51 / +0.19 (+1.68%) 06/22/20 Trump Effect: Analyst questions NYT 'agenda' after COVID funding article 03/25/20 Fly Intel: Pre-market Movers CCK Crown Holdings $69.63 / +1.375 (+2.01%) 07/15/20 Fly Intel: Wall Street's top stories for Wednesday 04/20/20 Fly Intel: After-Hours Movers ACAD Acadia $55.47 / +0.535 (+0.97%) 05/07/20 Fly Intel: After-Hours Movers 05/04/20 Fly Insider: Five Point, Acadia among week's notable insider trades 04/27/20 Fly Insider: Accelerate Diagnostics, Abbott among week's notable insider trades 03/12/20 Piper sees trial disruption risk, calls out Moderna, Inovio as 'COVID-19 plays' 08/05/20 Biotech Focus Virtual Conference 2020 07/20/20 Kiniksa - KNSA 07/20/20 Acadia - ACAD 07/20/20 Cadence Design - CDNS 07/20/20 IBM - IBM 07/21/20 Triumph Bancorp - TBK 07/21/20 New Age Beverages - NBEV 07/21/20 Crown Holdings - CCK 07/21/20 FB Financial - FBK 07/24/20 First Hawaiian - FHB 08/04/20 CytoSorbents - CTSO 04/03/21 PDUFA Date for NUPLAZID (Pimavanserin) IBM HSTO FBK CDNS IBM IBM $126.42 / +1.275 (+1.02%) 07/20/20 IBM options imply 7.3% move in share price post-earnings 07/20/20 Unusually active option classes on open July 20th 06/12/20 IBM call volume above normal and directionally bullish 05/12/20 IBM call volume above normal and directionally bullish HSTO Histogen $3.11 / -0.02 (-0.64%) 05/28/20 Thirteen new option listings and four option delistings on May 28th FBK FB Financial $22.75 / -0.83 (-3.52%) 04/08/20 Two new option listings and one option delisting on April 8th CDNS Cadence Design $103.85 / +3.62 (+3.61%) 07/20/20 Cadence Design options imply 8.5% move in share price post-earnings
Hot Stocks	S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices » 17:41 07/20/20 07/20 17:41 07/20/20 17:41 EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) , CZR Caesars $12.39 / -0.02 (-0.16%) , ERI Eldorado Resorts $38.18 / +0.18 (+0.47%) , FHB First Hawaiian $15.57 / -0.295 (-1.86%) Emergent BioSolutions… Emergent BioSolutions (EBS) will replace Caesars Entertainment (CZR) in the S&P MidCap 400, and First Hawaiian (FHB) will replace Emergent BioSolutions in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 24. S&P MidCap 400 constituent Eldorado Resorts (ERI) acquired Caesars Entertainment in a deal completed July 20. Post-merger, Eldorado Resorts will change its name to Caesars Entertainment and its ticker to CZR. It will remain in the S&P MidCap 400. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options FHB ERI EBS CZR FHB First Hawaiian $15.57 / -0.295 (-1.86%) 04/24/20 First Hawaiian suspends stock repurchase program ERI Eldorado Resorts $38.18 / +0.18 (+0.47%) 07/13/20 Eldorado Resorts gets Indiana HRC approval for Caesars deal EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) 07/20/20 First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24 07/20/20 Emergent BioSolutions to replace Caesars in S&P 400 at open on 7/24 07/08/20 Emergent BioSolutions enters collaboration with two others to evaluate COVID-HIG 07/06/20 Emergent enters five-year agreement with Janssen for Ad26.COV2-S manufacturing CZR Caesars $12.39 / -0.02 (-0.16%) 07/20/20 Caesars, Eldorado Resorts announced completion of merger 07/17/20 Eldorado Resorts secures NJ CCC approval in connection with Caesars deal 07/15/20 Caesars reports reopening performance for Regional and Destination properties EBS CZR ERI FHB EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) 07/17/20 Cantor Fitzgerald Emergent BioSolutions price target raised to $110 from $85 at Cantor Fitzgerald 07/02/20 Wells Fargo Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo 06/26/20 Raymond James Vaxart already had vaccine deals with Emergent, Kindred, notes Raymond James 06/08/20 Guggenheim Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim CZR Caesars $12.39 / -0.02 (-0.16%) 07/08/20 Jefferies Eldorado Resorts price target raised to $51 from $38 at Jefferies 06/29/20 Stifel Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon 06/04/20 Deutsche Bank Caesars price target raised to $12 from $11 at Deutsche Bank 06/02/20 Nomura Eldorado Resorts price target raised to $34 from $12.50 at Nomura Instinet ERI Eldorado Resorts $38.18 / +0.18 (+0.47%) 06/12/20 Truist SunTrust raises price target on select Gaming names amid positive room-rate data FHB First Hawaiian $15.57 / -0.295 (-1.86%) 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 06/29/20 UBS First Hawaiian downgraded to Sell from Neutral at UBS FHB ERI EBS CZR FHB First Hawaiian $15.57 / -0.295 (-1.86%) 04/24/20 First Hawaiian reports Q1 EPS 30c, consensus 38c 01/28/20 First Hawaiian reports Q4 adj. EPS 54c, consensus 51c ERI Eldorado Resorts $38.18 / +0.18 (+0.47%) 05/11/20 Eldorado Resorts reports Q1 adjusted EPS ($2.25) vs. 49c last year 02/26/20 Eldorado Resorts reports Q4 EPS (17c), consensus 31c 02/26/20 Notable companies reporting after market close EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) 04/30/20 Emergent BioSolutions reports Q1 EPS (1c), consensus 1c 02/20/20 Emergent BioSolutions sees FY20 revenue $1.175B-$1.275B, consensus $1.23B 02/20/20 Emergent BioSolutions sees Q1 revenue $190M-$215M, consensus $262.06M 02/20/20 Emergent BioSolutions reports Q4 EPS $1.57, consensus $1.73 CZR Caesars $12.39 / -0.02 (-0.16%) 05/11/20 Caesars reports Q1 EPS (36c), consensus (18c) 05/11/20 Notable companies reporting after market close 02/25/20 Caesars reports Q4 EPS (45c), may not compare to consensus (11c) 02/25/20 Notable companies reporting after market close 17 Jun ERI CZR ERI Eldorado Resorts $38.18 / +0.18 (+0.47%) 05/28/20 NJ commission won't review Caesars buyout at June meeting, M&A by Reorg says CZR Caesars $12.39 / -0.02 (-0.16%) 07/17/20 Eldorado-Caesars deal approved in New Jersey, Bloomberg reports 07/13/20 Eldorado, Caesars deal approved in Indiana, Casino News reports 07/08/20 Nevada Gaming Control Board recommends Eldorado-Caesars approval, Bloomberg says 06/28/20 Casinos consider cashless gambling to fight COVID, WSJ reports ERI EBS CZR ERI Eldorado Resorts $38.18 / +0.18 (+0.47%) 05/12/20 Fly Intel: Pre-market Movers EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) 06/08/20 Fly Intel: Wall Street's top stories for Monday 06/08/20 Fly Intel: Wall Street's top stories at midday 04/27/20 Fly Insider: Accelerate Diagnostics, Abbott among week's notable insider trades 04/23/20 Fly Intel: After-Hours Movers CZR Caesars $12.39 / -0.02 (-0.16%) 07/20/20 Fly Intel: Wall Street's top stories for Monday 05/11/20 Fly Intel: After-Hours Movers 03/31/20 Fly Intel: Wall Street's top stories for Tuesday 03/18/20 Fly Intel: Wall Street's top stories for Wednesday 07/24/20 First Hawaiian - FHB 07/30/20 Emergent BioSolutions - EBS ERI CZR ERI Eldorado Resorts $38.18 / +0.18 (+0.47%) 07/17/20 Eldorado Resorts call volume above normal and directionally bullish 06/24/20 Eldorado Resorts put volume heavy and directionally bearish 05/27/20 Largest borrow rate increases among liquid names CZR Caesars $12.39 / -0.02 (-0.16%) 07/17/20 Unusually active option classes on open July 17th 07/17/20 Notable open interest changes for July 17th 07/14/20 Largest borrow rate increases among liquid names 07/07/20 Caesars put volume heavy and directionally bearish
Hot Stocks	First Hawaiian to replace Emergent BioSolutions in S&P 600 at open on 7/24 17:19 07/20/20 07/20 17:19 07/20/20 17:19 FHB First Hawaiian $15.57 / -0.295 (-1.86%) , EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FHB EBS FHB First Hawaiian $15.57 / -0.295 (-1.86%) 04/24/20 First Hawaiian suspends stock repurchase program EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) 07/20/20 Emergent BioSolutions to replace Caesars in S&P 400 at open on 7/24 07/08/20 Emergent BioSolutions enters collaboration with two others to evaluate COVID-HIG 07/06/20 Emergent enters five-year agreement with Janssen for Ad26.COV2-S manufacturing 06/18/20 Emergent BioSolutions investing $75M in Canton site expansion FHB EBS FHB First Hawaiian $15.57 / -0.295 (-1.86%) 07/07/20 Fly Intel: Top five analyst downgrades 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 06/29/20 UBS First Hawaiian downgraded to Sell from Neutral at UBS EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) 07/17/20 Cantor Fitzgerald Emergent BioSolutions price target raised to $110 from $85 at Cantor Fitzgerald 07/02/20 Wells Fargo Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo 06/26/20 Raymond James Vaxart already had vaccine deals with Emergent, Kindred, notes Raymond James 06/08/20 Guggenheim Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim FHB EBS FHB First Hawaiian $15.57 / -0.295 (-1.86%) 04/24/20 First Hawaiian reports Q1 EPS 30c, consensus 38c 01/28/20 First Hawaiian reports Q4 adj. EPS 54c, consensus 51c EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) 04/30/20 Emergent BioSolutions reports Q1 EPS (1c), consensus 1c 02/20/20 Emergent BioSolutions sees FY20 revenue $1.175B-$1.275B, consensus $1.23B 02/20/20 Emergent BioSolutions sees Q1 revenue $190M-$215M, consensus $262.06M 02/20/20 Emergent BioSolutions reports Q4 EPS $1.57, consensus $1.73 EBS EBS Emergent BioSolutions $102.04 / -2.1 (-2.02%) 06/08/20 Fly Intel: Wall Street's top stories for Monday 06/08/20 Fly Intel: Wall Street's top stories at midday 04/27/20 Fly Insider: Accelerate Diagnostics, Abbott among week's notable insider trades 04/23/20 Fly Intel: After-Hours Movers 07/24/20 First Hawaiian - FHB 07/30/20 Emergent BioSolutions - EBS
Downgrade	Fly Intel: Top five analyst downgrades » 10:03 07/07/20 07/07 10:03 07/07/20 10:03 KMI Kinder Morgan $14.74 / -0.46 (-3.03%) , CZZ Cosan $17.68 / -0.15 (-0.84%) , D Dominion $72.55 / -1.045 (-1.42%) , FHB First Hawaiian $16.08 / -0.66 (-3.94%) , YETI Yeti $43.00 / -0.09 (-0.21%) Catch up on today's… Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kinder Morgan (KMI) downgraded to Sell from Neutral at Goldman Sachs with analyst Michael Lapides citing the stock's valuation and expects shares to lag large-cap midstream peers in the second half of 2020. 2. Cosan (CZZ) downgraded to Neutral from Overweight at JPMorgan with analyst Lucas Ferreira citing valuation. 3. Dominion (D) was downgraded to Neutral from Outperform at Credit Suisse and to Underperform from Neutral at Mizuho. 4. First Hawaiian (FHB) downgraded to Underweight from Equal Weight at Wells Fargo with analyst Jared Shaw saying the reality of the Hawaiian economy, among the hardest hit in the U.S. with a recovery expected to be the slowest, doesn't "square" with the current 30% TBV premium valuation. 5. Yeti (YETI) downgraded to Neutral from Buy at Goldman Sachs with analyst Alexandra Walvis saying the company's "strong" brand momentum and growth opportunity is now better understood by investors and reflected in the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options YETI KMI FHB D CZZ YETI Yeti $43.00 / -0.09 (-0.21%) 05/25/20 Fly Intel: Top five weekend stock stories 04/17/20 Yeti to replace LHC Group in S&P 600 at open on 4/17 04/14/20 Yeti rises 13.2% KMI Kinder Morgan $14.74 / -0.46 (-3.03%) 04/22/20 Kinder Morgan raises annual dividend 5% to $1.05 03/08/20 Fly Intel: Top five weekend stock stories 01/09/20 Kinder Morgan announces sale of 25M shares of Pembina Pipeline FHB First Hawaiian $16.08 / -0.66 (-3.94%) 04/24/20 First Hawaiian suspends stock repurchase program D Dominion $72.55 / -1.045 (-1.42%) 07/06/20 Dominion dividend cut 'not permanent' 07/06/20 Dominion plans to spend 'tens of billions' on renewables 07/06/20 Dominion: Sale of gas operations is 'right step at right time' 07/06/20 Dominion: Sale of gas operations will enhance credit profile CZZ Cosan $17.68 / -0.15 (-0.84%) 03/09/20 Cosan trading resumes 03/09/20 Cosan trading halted, volatility trading pause KMI CZZ D FHB YETI KMI Kinder Morgan $14.74 / -0.46 (-3.03%) 07/06/20 Goldman Sachs Kinder Morgan downgraded to Sell from Neutral at Goldman Sachs 05/18/20 BofA Plains All American, GP Holdings cut to Underperform at BofA 04/07/20 Mizuho Kinder Morgan price target lowered to $20 from $23 at Mizuho 03/24/20 Barclays Kinder Morgan upgraded to Overweight from Equal Weight at Barclays CZZ Cosan $17.68 / -0.15 (-0.84%) 07/07/20 JPMorgan Cosan downgraded to Neutral from Overweight at JPMorgan 05/27/20 HSBC Cosan downgraded to Hold from Buy at HSBC 05/20/20 Goldman Sachs Cosan downgraded to Neutral from Buy at Goldman Sachs 11/05/19 Bradesco BBI Cosan downgraded to Neutral from Outperform at Bradesco D Dominion $72.55 / -1.045 (-1.42%) 07/07/20 Argus Dominion price target lowered to $80 from $87 at Argus 07/07/20 Mizuho Dominion downgraded to Underperform from Neutral at Mizuho 07/07/20 Credit Suisse Dominion downgraded to Neutral from Outperform at Credit Suisse 07/06/20 Wells Fargo Wells says merits of Dominion's 'forward-looking' deal to be clearer with time FHB First Hawaiian $16.08 / -0.66 (-3.94%) 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 07/07/20 Wells Fargo First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo 06/29/20 UBS First Hawaiian downgraded to Sell from Neutral at UBS 06/29/20 UBS First Hawaiian downgraded to Sell from Neutral at UBS YETI Yeti $43.00 / -0.09 (-0.21%) 07/07/20 Goldman Sachs Yeti downgraded to Neutral from Buy at Goldman Sachs 06/23/20 Piper Sandler Yeti price target raised to $47 from $35 at Piper Sandler 06/10/20 Cowen Yeti price target raised to $41 from $31 at Cowen 06/09/20 BTIG Yeti price target raised to $44 from $36 at BTIG YETI KMI FHB D YETI Yeti $43.00 / -0.09 (-0.21%) 05/07/20 Yeti withdraws 2020 guidance 02/13/20 Yeti sees FY20 adjusted EPS $1.34-$1.39, consensus $1.37 02/13/20 Yeti reports Q4 adjusted EPS 48c, consensus 43c 02/12/20 Notable companies reporting before tomorrow's open KMI Kinder Morgan $14.74 / -0.46 (-3.03%) 04/22/20 Kinder Morgan sees FY20 adjusted EBITDA below plan by about 8% 04/22/20 Kinder Morgan reports Q1 adjusted EPS 24c, consensus 27c 04/22/20 Notable companies reporting after market close 01/22/20 Kinder Morgan sees FY20 adjusted EBITDA roughly $7.6B FHB First Hawaiian $16.08 / -0.66 (-3.94%) 04/24/20 First Hawaiian reports Q1 EPS 30c, consensus 38c 01/28/20 First Hawaiian reports Q4 adj. EPS 54c, consensus 51c D Dominion $72.55 / -1.045 (-1.42%) 07/06/20 Dominion sees FY20 EPS ~$3.50, consensus $4.35 05/05/20 Dominion backs FY20 EPS view of $4.25-$4.60, consensus $4.37 05/05/20 Dominion sees Q2 EPS 75c-85c, consensus 92c 05/05/20 Dominion reports Q1 EPS $1.09, consensus $1.10 28 May 11 May 17 Feb 07 Nov YETI KMI D YETI Yeti $43.00 / -0.09 (-0.21%) 05/23/20 Americans rushing to 'the great outdoors,' Barron's says 01/21/20 Yeti, Columbia suggested by Dealreporter as targets if VF Corp. seeks big deal KMI Kinder Morgan $14.74 / -0.46 (-3.03%) 03/07/20 AT&T, Dow among dividend stocks to buy amid coronavirus selloff, Barron's says D Dominion $72.55 / -1.045 (-1.42%) 06/15/20 Supreme Court overrules lower court on Atlantic Coast Pipeline, Reuters reports 06/15/20 Supreme Court overrules lower court on Atlantic Coast pipeline permit, WSJ says 04/11/20 American Electric, FirstEnergy among stocks with dividend safety, Barron's says 02/24/20 Supreme Court looks ready to back permit for Dominion pipeline, Bloomberg says YETI KMI D YETI Yeti $43.00 / -0.09 (-0.21%) 03/03/20 Tesla, AMD, UPS upgrades among today's top analyst calls 02/24/20 Fly Insider: Tesla, Netflix among weeks notable insider trades 01/30/20 Fly Intel: Wall Street's top stories for Thursday 01/30/20 Fly Intel: Wall Street's top stories at midday KMI Kinder Morgan $14.74 / -0.46 (-3.03%) 07/06/20 Fly Intel: After-Hours Movers 03/16/20 Costo, Autozone upgrades among today's top calls on Wall Street D Dominion $72.55 / -1.045 (-1.42%) 07/07/20 Fly Intel: Pre-market Movers 07/06/20 Fly Intel: Wall Street's top stories for Monday 07/06/20 Fly Intel: Wall Street's top stories at midday 07/06/20 Fly Intel: Pre-market Movers 07/24/20 First Hawaiian - FHB KMI D KMI Kinder Morgan $14.74 / -0.46 (-3.03%) 04/23/20 Kinder Morgan call volume above normal and directionally bullish 04/22/20 Kinder Morgan call volume above normal and directionally bullish 03/06/20 Kinder Morgan call volume above normal and directionally bullish 02/28/20 Kinder Morgan put volume heavy and directionally bearish D Dominion $72.55 / -1.045 (-1.42%) 07/06/20 Unusually active option classes on open July 6th 04/01/20 Dominion call volume above normal and directionally bullish 03/27/20 Dominion call volume above normal and directionally bullish

On The Fly

News and insights, exclusive to thefly.com

10:44	MicroStrategy buys 328 additional bitcoins for $15M, now holds 90,859»
09:53	Fly Intel: Top five analyst initiations»
09:53	Fly Intel: Top five analyst downgrades»
09:53	Fly Intel: Top five analyst upgrades»
06:46	JPMorgan upgrades Plug Power on 'many long-term growth opportunities'»

View all On The Fly Stories »

Upcoming
Events (10)

DMYD	dMY Technology II - DMYD
OOMA	Ooma - OOMA
SMMNY ...	European Medtech & Services Virtual Conference
BL ...	Technology Virtual Conference 2021
FCX ...	30th Global Metals & Mining Virtual Conference
AIG ...	46th Annual Virtual Conference of AIFA 2021
PAM ...	Global Emerging Markets Corporate Virtual Conference
BNPQY ...	2021 Annual Washington Virtual Conference
	AAAAI Virtual Annual Meeting 2021
CYBR ...	Technology, Media & Telecom Virtual Conference

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals for your search.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial